Fig. 1From: Development and validation of a nomogram for evaluating the prognosis of immunotherapy plus antiangiogenic therapy in non-small cell lung cancerThe number of neutrophils A, lymphocytes B and the proportion of B cells C, Treg cells D of survival and dead patients in training cohortBack to article page